Researchers have recognized a receptor, CD169 (additionally known as Siglec1), that’s solely expressed on macrophages and contributes to the hyper-inflammatory response of macrophages upon an infection with SARS-CoV-2. These findings, they imagine, might present a proof of how SARS-CoV-2 an infection of macrophages in lungs of COVID-19 sufferers promote inflammatory responses.